# Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections

> **NCT02784704** · PHASE3 · COMPLETED · sponsor: **Tetraphase Pharmaceuticals, Inc** · enrollment: 500 (actual)

## Conditions studied

- Complicated Intra-abdominal Infections
- Complicated Appendicitis

## Interventions

- **DRUG:** Eravacycline
- **DRUG:** Meropenem
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02784704
- **Lead sponsor:** Tetraphase Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-13
- **Primary completion:** 2017-05-08
- **Final completion:** 2017-05-19
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2022-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02784704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02784704, "Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02784704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*